YNdiagnostics  
+972 53 374 92 23
e-mail support@yndiagnostics.info
עבר | Eng

Request a call back >
DNA diagnostic A/S

HemaVison®-28Q
28 translocations
more than 145 breakpoints

DNA diagnostic A/S

DNA diagnostic A/S

Multiplex RT-qPCR test
Size: 12 tests

DNA Diagnostic A/S
Denmark
HemaVision®-28Q [CE/IVD] by DNA Diagnostic A/S

the 4 hour in vitro diagnostic test for qualitative screening of 28 chromosome translocations and more than 145 breakpoints associated with chronic and acute leukemia. HemaVision®-28Q is intended for testing total RNA samples from human blood or bone marrow for presence of chromosomal translocations associated with leukemia. It is a qualitative, semi-automated test. HemaVision®-28Q detects RNA transcripts from fusion genes using a RT-qPCR procedure. Alternative splice variants are also detected

HemaVision®-28Q detects the following 28 translocations:
del1(p32) (STIL-TAL1)
t(1;11) (p32;q23.3) (KMT2A-EPS15)
t(1;11) (q21;q23.3) (KMT2A-MLLT11)
t(1;19) (q23;p13) (TCF3-PBX1)
t(3;5) (q25;q34) (NPM1-MLF1)
t(3;21) (q26;q22) (RUNX1-MECOM)
t(4;11) (q21;q23.3) (KMT2A-AFF1)
t(5;12) (q33;p13) (ETV6-PDGFRB)
t(5;17) (q35;q21) (NPM1-RARA)
t(6;9) (p23;q34) (DEK-NUP214)
t(6;11) (q27;q23.3) (KMT2A-AFDN)
t(8;21) (q22;q22) (RUNX1-RUNX1T1)
t(9;9) (q34;q34) (SET-NUP214)
t(9;11) (p21.3;q23.3) (KMT2A-MLLT3)
t(9;12) (q34;p13) (ETV6-ABL1)
t(9,22) (q34;q11) (BCR-ABL1)
t(10;11) (p12;q23.3) (KMT2A-MLLT10)
t(11;17) (q23.3;q21) (KMT2A-MLLT6)
t(11;17) (q23;q21) (ZBTB16-RARA)
t(11;19) (q23.3;p13.1) (KMT2A-ELL)
t(11;19) (q23.3;p13.3) (KMT2A-MLLT1)
t(12;21) (p13;q22) (ETV6-RUNX1)
t(12;22) (p13;q11) (ETV6-MN1)
t(15;17) (q24;q21) (PML-RARA)
inv(16) (p13;q22) (CBFB-MYH11)
t(16;21) (p11;q22) (FUS-ERG)
t(17;19) (q22;p13) (TCF3-HLF)
t(X;11) (q13;q23.3) (KMT2A-FOXO4)

DNA diagnostic A/S

HemaVison®-7Q
7 translocations
more than 40 breakpoints



DNA diagnostic A/S

Multiplex RT-qPCR test
Size: 12 tests

DNA Diagnostic A/S
Denmark
HemaVision®-7Q [CE/IVD] by DNA Diagnostic A/S

the 4 hour in vitro diagnostic test for qualitative screening of 7 chromosome translocations and more than 40 breakpoints associated with chronic and acute leukemia. HemaVision®-7Q is intended for testing total RNA samples from human blood or bone marrow for presence of chromosomal translocations associated with leukemia. It is a qualitative, semi-automated test. HemaVision®-7Q detects RNA transcripts from fusion genes using a RT-qPCR procedure. Alternative splice variants are also detected

HemaVision®-7Q detects the following 7 translocations:
t(1;19) (q23;p13) (TCF3-PBX1)
t(4;11) (q21;q23) (KMT2A-AFF1)
t(8;21) (q22;q22) (RUNX1-RUNX1T1)
t(9,22) (q34;q11) (BCR-ABL1)
t(12;21) (p13;q22) (ETV6-RUNX1)
t(15;17) (q24;q21) (PML-RARA)
inv(16) (p13;q22) (CBFB-MYH11)

Downloads
  HV-28Q Instruction For Use (Eng)
  HV-7Q Instruction For Use (Eng)
  HemaVision Product Sheet (Eng)
  HV-28Q HemaVision Safety Data Sheet (Eng)
  HV-7Q HemaVision Safety Data Sheet (Eng)

Ordering Information
Cat No.
HV01-28Q
HemaVision®-28Q
Supplied in qPCR tubes: WRP/WLP/FRP
Size: 12 tests

DNA Diagnostic A/S
Denmark

IFU
Cat No.
HV01-7Q
HemaVision®-7Q
Supplied in qPCR tubes: WLP/WLP/FRP
Size: 12 tests

DNA Diagnostic A/S
Denmark

IFU